comparemela.com

Latest Breaking News On - Symmetry peak management - Page 2 : comparemela.com

Augmedix, Inc. (NASDAQ:AUGX) Insider Ian Shakil Sells 24,778 Shares

Augmedix, Inc. (NASDAQ:AUGX) Insider Ian Shakil Sells 24,778 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Mian-shakil
Thompson-davis
Augmedix-inc
Acadian-asset-management
Barclays-plc
Nasdaq
Maxim-group
Worth-venture-partners
Symmetry-peak-management
Get-free-report
Asset-management

Short Interest in Asset Entities Inc. (NASDAQ:ASST) Increases By 716.6%

Asset Entities Inc. (NASDAQ:ASST – Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 191,900 shares, a growth of 716.6% from the March 15th total of 23,500 shares. Currently, 7.1% of the shares of the stock are short sold. Based […]

Dallas
Texas
United-states
Symmetry-peak-management
Asset-entities-company-profile
Nasdaq
Geode-capital-management
Asset-entities-holdings-llc
Asset-entities-inc
Sigma-securities
Asset-entities

Asset Entities Inc. (NASDAQ:ASST) Short Interest Update

Asset Entities Inc. (NASDAQ:ASST – Get Free Report) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 191,900 shares, an increase of 716.6% from the March 15th total of 23,500 shares. Based on an average daily trading volume, of 743,000 shares, the short-interest ratio is currently […]

Texas
United-states
Dallas
Asset-entities-holdings-llc
Symmetry-peak-management
Geode-capital-management
Sigma-securities
Nasdaq
Asset-entities-inc
Asset-entities
Get-free-report

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

United-states
Mian-shakil
Augmedix-company-profile
Securities-exchange-commission
Verition-fund-management
Symmetry-peak-management
Maxim-group
Nasdaq
Acadian-asset-management
Augmedix-inc
Worth-venture-partners
Thompson-davis

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

United-states
Mian-shakil
Worth-venture-partners
Thompson-davis
Securities-exchange-commission
Augmedix-company-profile
Maxim-group
Acadian-asset-management
Nasdaq
Symmetry-peak-management
Verition-fund-management
Augmedix-inc

vimarsana © 2020. All Rights Reserved.